News and Events

  • Recent Releases

    09/04/2014 - 9:30am

    New $2.3 million workplace intervention aims to reduce exposure risk for oncology nurses

    Researchers at the University of Michigan School of Nursing and Comprehensive Cancer Center have received a $2.3 million grant to study oncology nurses’ exposure to hazardous drugs, including identifying ways to reduce exposure. According to Christopher Friese, Ph.D., R.N., AOCN, FAAN, University of Michigan School of Nursing assistant professor and member of U-M’s Comprehensive Cancer Center and Institute for Healthcare Policy and Innovation, there are significant acute and long-term side effects from hazardous drug exposures in oncology settings, but not enough evidence-based, risk-reduction efforts to protect health care workers.

    09/03/2014 - 10:00am

    A one-two punch for brain tumors? New clinical trial opens at U-M

    Gene therapy developed by Dr. Maria Castro and Dr. Pedro Lowenstein will now get the first test in human patients. The experimental approach, based on their research while at the University of Michigan, delivers two different genes directly into the brains of patients following the operation to remove the bulk of their tumors.
    08/12/2014 - 10:30am

    Breast cancer research at U-M benefits from multi-platform charitable shoe sale on QVC

    QVC and FFANY presented a check for $342,143 to the Cancer Center's Breast Oncology Program, one of nine beneficiaries of the 2013 QVC Presents "FFANY Shoes on Sale" event, in which 75,000 pairs of shoes were ordered at half the manufacturer’s suggested retail price, all in the name of cancer awareness.

    08/07/2014 - 2:15pm

    Brain tumors fly under the body's radar like stealth jets, new U-M research suggests

    Like a stealth fighter jet, the coating means the cells evade detection by the early-warning immune system that should detect and kill them. The stealth approach lets the tumors hide until it’s too late for the body to defeat them.
    08/07/2014 - 9:45am

    Gut microbiome analysis improved noninvasive colorectal cancer screening

    Analysis of the gut microbiome more successfully distinguished healthy individuals from those with precancerous adenomatous polyps and those with invasive colorectal cancer compared with assessment of clinical risk factors and fecal occult blood testing, according to a new study.

    All Releases